Óscar Fernández

Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study

Giancarlo Comi, Massimo Filippi, Frederik Barkhof et al. · The Lancet · 2001 · 1.1K citations

Autoimmune Disease, Neurological Disorder, Immunology +9

Validation of the Multiple Sclerosis International Quality of Life questionnaire

M.C. Simeoni, Pascal Auquier, Óscar Fernández et al. · Multiple Sclerosis Journal · 2007 · 190 citations

Intravenous immunoglobulin in secondary progressive multiple sclerosis: randomised placebo-controlled trial

O. R. Hommes, Per Soelberg Sørensen, Franz Fazekas et al. · The Lancet · 2004 · 183 citations

Autoimmune Disease, Intravenous Immunoglobulin, Immunodeficiencies +9

Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial

Diego Cadavid, Michelle Mellion, Raymond Hupperts et al. · The Lancet Neurology · 2019 · 173 citations

Neurological Disorder, Clinical Neurology, Clinical Trials +5

Genome-Wide Pharmacogenomic Analysis of the Response to Interferon Beta Therapy in Multiple Sclerosis

Esther Byun, Stacy J. Caillier, Xavier Montalbán et al. · Archives of Neurology · 2008 · 170 citations